FB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans | Cardiovascular research |  | 2023 | 17 | 11 | ||
| Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I | Research and practice in thrombosis and haemostasis | | 2022 | 133 | 103 | ||
| High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD? | 90th European Atherosclerosis Society (EAS) congress | 2022 | 118 | 0 | |||
| Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease | International journal of molecular sciences | | 2022 | 143 | 165 | ||
| Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells | Cells | | 2022 | 153 | 140 | ||
| NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis | International journal of molecular sciences | | 2021 | 162 | 125 | ||
| Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease | 89th Europen Society of Atherosclerosis (EAS) | 2021 | 59 | 0 | |||
| Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet | Cardiovascular Research | | 2021 | 151 | 70 | ||
| Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques | International Journal of Molecular Sciences | | 2020 | 187 | 87 | ||
| Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression | Scientific Reports | | 2020 | 165 | 148 | ||
| Atherosclerotic plaque vulnerability is increased in mouse model of lupus | Scientific Reports | | 2020 | 274 | 173 | ||
| Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 | Thrombosis and Haemostasis |  | 2020 | 188 | 0 | ||
| Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population | Clinical & translational immunology | | 2020 | 138 | 81 | ||
| Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence | Journal of cardiovascular medicine | | 2020 | 144 | 0 | ||
| Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | 2016 | 499 | 0 | |||
| Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | | 2016 | 534 | 1 | ||
| Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis | Thrombosis and haemostasis | | 2016 | 669 | 1 | ||
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | | 2016 | 565 | 6 | ||
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | | 2016 | 681 | 527 | ||
| Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | | 2016 | 435 | 163 | ||
| Leptin/adiponectin ratio predicts post-stroke neurological outcome | European journal of clinical investigation | | 2015 | 522 | 1 | ||
| Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | | 2015 | 573 | 0 | ||
| Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways | European heart journal | | 2015 | 588 | 2 | ||
| Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | | 2015 | 667 | 0 | ||
| Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways | Vascular pharmacology | | 2015 | 778 | 4 | ||
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | | 2015 | 726 | 0 | ||
| Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | | 2015 | 547 | 0 | ||
| Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | | 2015 | 576 | 5 | ||
| Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | | 2014 | 599 | 0 | ||
| Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | | 2014 | 725 | 0 | ||
| Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice | Thrombosis and haemostasis | | 2013 | 683 | 0 | ||
| Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice | Journal of cerebral blood flow and metabolism | | 2013 | 656 | 0 | ||
| Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury | Journal of Molecular and Cellular Cardiology | | 2013 | 592 | 0 | ||
| Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice | Arteriosclerosis, thrombosis, and vascular biology | | 2013 | 446 | 1 | ||
| The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques | European heart journal | | 2012 | 656 | 0 | ||
| Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice | Journal of Molecular and Cellular Cardiology | | 2010 | 656 | 0 | ||
| CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion | Journal of Molecular and Cellular Cardiology | | 2009 | 722 | 0 | ||
| HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | | 2009 | 614 | 0 | ||
| Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes | Rheumatology | | 2009 | 599 | 0 | ||
| Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis | Atherosclerosis | | 2009 | 560 | 0 | ||
| Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways | Cellular signalling | | 2008 | 642 | 0 | ||
| C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes | Journal of leukocyte biology | | 2008 | 591 | 0 | ||
| CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways | American journal of physiology. Heart and circulatory physiology | | 2008 | 572 | 0 | ||
| A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice | Arteriosclerosis, thrombosis, and vascular biology | | 2008 | 612 | 0 | ||
| Atorvastatin treatment and vaccination efficacy | Journal of clinical pharmacology | | 2007 | 565 | 0 |
